Our news

  • Cochrane Hypertension publishes a quarterly newsletter with updates on our systematic reviews, training, and other editorial team activities and news. Subscribe to the Cochrane HTN newsletter.Our latest newsletter (Winter 2021) is now availableIf you have feedback on current or past newsletters, or suggestions for future newsletter...
    January 30 2021
  • Plain language conclusions:BackgroundWe conducted this review to find and assess all trials designed to evaluate whether lower blood pressure targets are better than standard blood pressure targets for people with hypertension. The main objective in the treatment of hypertension is to prevent serious vascular complications. For the general...
    December 18 2020
  • Alcohol has a biphasic effect on blood pressure and increases heart rateReview questionWe reviewed available evidence about the short‐term effects of different doses of alcoholic drinks compared to non‐alcoholic drinks on blood pressure and heart rate in adults (≥ 18 years) with both normal and raised blood pressure. BackgroundDrinking...
    September 7 2020
  • Plain language conclusions:BackgroundHigh blood pressure, also known as hypertension, is very common in the general population, and if not treated, can increase the risk of stroke and heart disease. In an individual, blood pressure naturally varies throughout the day. It is at its lowest at night, rises before awakening, and then falls...
    September 7 2020
  • Cochrane Hypertension publishes a quarterly newsletter with updates on our systematic reviews, training, and other editorial team activities and news. Subscribe to the Cochrane HTN newsletter.Our latest newsletter (Autumn 2020) is now availableIf you have feedback on current or past newsletters, or suggestions for future newsletter...
    September 7 2020
  • Implications for practice1. Pitavastatin causes a linear dose‐response reduction in the per cent change from control of blood LDL cholesterol, total cholesterol and blood triglycerides. There is no dose‐response relationship for HDL cholesterol which is increased by 4% on average for all doses. This effect on HDL is not different...
    June 19 2020
  • Cochrane Hypertension publishes a quarterly newsletter with updates on our systematic reviews, training, and other editorial team activities and news. Subscribe to the Cochrane HTN newsletter.Our latest newsletter (Spring 2020) is now availableIf you have feedback on current or past newsletters, or suggestions for future newsletter...
    June 18 2020
  • Conclusions:There is an implicit assumption that early detection fo hypertension through screening can reduce the burden of morbidity and mortality, but this assumption has not been tested in rigorous research studiesHigh-quality evidence from RCTs or programmatic evidence from NRCTs on the effectiveness and costs or harms of different screening...
    June 12 2020
  • Plain language conclusions:It may be safe to stop antihypertensive medications in older people who are taking the medication for high blood pressure or primary prevention of heart diseaseOlder adults should not stop any of their medications with out talking to a healthcare professionalFuture studies should include older adults who are taking...
    June 12 2020
  • Introducing the Cochrane Circulation & Breathing NetworkWatch the video: https://buff.ly/2XlwLJEThis network covers the work of  Cochrane Hypertension, Cochrane Airways, Cochrane Heart, Cochrane Stroke, and Cochrane Vascular
    July 8 2019

Pages

Subscribe to Our news